Speaking at an investment conference at the UCLA
After this one he'll be hot footing it over to the Claremont McKenna College for a Q&A session at 19.15 GMT.
After this one he'll be hot footing it over to the Claremont McKenna College for a Q&A session at 19.15 GMT.
Most Popular
Pfizer's pipeline fuels growth hopes, but drug trial failures pose key risk. Obesity drug market offers huge revenue potential.
Nvidia's revenue forecast doubles, boosting Asian tech. Oil surge & Iran conflict add risk.
Independent Reserve eyes APAC growth with corporate crypto payments & yield products. Revenue jumped 88% to A$35.3M.
Argentina's wine exports drop 6.8% amid low consumption & high costs. Quality is key to survival.
Australia's diesel prices surge 50% amid Middle East conflict; supply risks loom.
Musk's $44B Twitter deal faces trial over bot claims. Shareholders allege deception, impacting valuation.
Nvidia's AI chip boom fuels 200% YTD gains, but P/E ratio nears 80. Is it a buy?
Must Read